Successful 2-year therapy with systemic interferon-alpha for HTLV-I associated myelopathy

J Neurol Sci. 1999 Jan 15;162(2):205-7. doi: 10.1016/s0022-510x(98)00330-x.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adult
  • Antiviral Agents / therapeutic use*
  • Female
  • Humans
  • Interferon-alpha / therapeutic use*
  • Paraparesis, Tropical Spastic / drug therapy*
  • Time Factors
  • Treatment Outcome

Substances

  • Antiviral Agents
  • Interferon-alpha